- Home
- AFCG vs NVCT Comparison
AFCG vs NVCT Comparison
Compare AFCG & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFCG
- NVCT
- Stock Information
- Founded
- AFCG 2020
- NVCT 2020
- Country
- AFCG United States
- NVCT United States
- Employees
- AFCG N/A
- NVCT N/A
- Industry
- AFCG Real Estate Investment Trusts
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- AFCG Real Estate
- NVCT Health Care
- Exchange
- AFCG Nasdaq
- NVCT Nasdaq
- Market Cap
- AFCG 189.9M
- NVCT 170.3M
- IPO Year
- AFCG 2021
- NVCT 2022
- Fundamental
- Price
- AFCG $6.09
- NVCT $10.46
- Analyst Decision
- AFCG Buy
- NVCT Strong Buy
- Analyst Count
- AFCG 7
- NVCT 2
- Target Price
- AFCG $11.00
- NVCT $15.00
- AVG Volume (30 Days)
- AFCG 286.9K
- NVCT 125.3K
- Earning Date
- AFCG 03-13-2025
- NVCT 05-06-2025
- Dividend Yield
- AFCG 21.70%
- NVCT N/A
- EPS Growth
- AFCG N/A
- NVCT N/A
- EPS
- AFCG 0.78
- NVCT N/A
- Revenue
- AFCG $41,494,025.00
- NVCT N/A
- Revenue This Year
- AFCG $23.46
- NVCT N/A
- Revenue Next Year
- AFCG $14.49
- NVCT N/A
- P/E Ratio
- AFCG $7.81
- NVCT N/A
- Revenue Growth
- AFCG N/A
- NVCT N/A
- 52 Week Low
- AFCG $6.07
- NVCT $4.44
- 52 Week High
- AFCG $10.88
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- AFCG 22.08
- NVCT 67.09
- Support Level
- AFCG $6.15
- NVCT $8.45
- Resistance Level
- AFCG $6.52
- NVCT $10.67
- Average True Range (ATR)
- AFCG 0.37
- NVCT 0.96
- MACD
- AFCG -0.07
- NVCT 0.11
- Stochastic Oscillator
- AFCG 0.81
- NVCT 94.26
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to state-law-compliant cannabis operators in the U.S. Through the management team's deep network and significant credit and cannabis expertise, AFC originates, structures and underwrites loans ranging from $10 million to over $100 million, typically secured by quality real estate assets, license value and cash flows.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.